Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE

Standard Dose
12.5MG;1000MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 218483 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE Form and strength TABLET;ORAL - 12.5MG;1000MG Sponsor PRINSTON PHARMA INC Submission history Latest submission status date: 2024-10-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 218483 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE Form and strength TABLET;ORAL - 12.5MG;1000MG Sponsor PRINSTON PHARMA INC Submission history Latest submission status date: 2024-10-15 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE (EMPAGLIFLOZIN;METFORMIN HYDROCHLORIDE) | Drug Monograph | MedicHelpline